Are outcomes WORSE with tigecycline (Tygacil) compared with other antibiotics
October 2012
Please see the September 2013 FDA update regarding the increased risk of death with Tygacil
New evidence is saying "yes."
Initial studies suggested that tigecycline is comparable to vancomycin plus aztreonam for skin infections...imipenem for intra-abdominal infections...and levofloxacin for community-acquired pneumonia. But many of these patients weren't seriously ill.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote